Pfizer, the sole licensed UK supplier, is experiencing a short term supply issue. Stock is due back on 10th April. This memo discusses alternative treatment options in the interim.
NOTE: Although the shortage has resolved, the memo has been retained, as this product is subject to intermittent shortages. The contents of the memo, however, have not been updated since the publication date.